TCM
VCYT icon

Timpani Capital Management’s Veracyte VCYT Stock Holding History

Timpani Capital Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$2.68M Buy
106,965
+31,053
+41% +$593K 1.28% 33
2018
Q4 		$955K Sell
75,912
-90,835
-54% -$1.07M 0.54% 69
2018
Q3 		$1.59M Buy
+166,747
New +$1.84M 0.46% 72

Other funds holding VCYT

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Timpani Capital Management's VCYT Position: Q1 2019 in Review

Timpani Capital Management increased its Veracyte (VCYT) stake by 41% in Q1 2019, buying an estimated $593K and bringing the position to 106,965 shares worth $2.68M. The position accounts for 1.28% of the portfolio, ranked #33.

Timpani Capital Management first reported a position in VCYT in Q3 2018 and has held it in 3 quarters since. 149 funds tracked by Wall St. Rank hold VCYT as of Q1 2019.

  • Timpani Capital Management held 106,965 shares of Veracyte worth $2.68M as of Q1 2019.
  • Timpani Capital Management bought 31,053 Veracyte shares in Q1 2019, an estimated $593K.
  • Veracyte made up 1.28% of Timpani Capital Management's portfolio in Q1 2019, its #33 holding.
  • Timpani Capital Management first reported a position in Veracyte in Q3 2018 and has held it in 3 quarters since.
  • 149 funds tracked by Wall St. Rank held Veracyte as of Q1 2019.

Based on Timpani Capital Management's 13F filing for Q1 2019, filed 10 May 2019.